Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

This study has been completed.
Sponsor:
Collaborators:
Connecticut State, Department of Mental Health and Addiction Services
Eli Lilly and Company
Information provided by:
Yale University
ClinicalTrials.gov Identifier:
NCT00400166
First received: November 15, 2006
Last updated: June 10, 2009
Last verified: June 2009
  Purpose

The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience high rates of inpatient hospitalizations.


Condition Intervention
Schizophrenia
Schizoaffective Disorder
Bipolar Disorder
Psychotic Depression
Behavioral: Recovery Mentor

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

Resource links provided by NLM:


Further study details as provided by Yale University:

Primary Outcome Measures:
  • Number of hospitalizations [ Time Frame: 9 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Sense of community [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
  • Motivation for change [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
  • Social functioning [ Time Frame: Baseline, 3 abd 9 months ] [ Designated as safety issue: No ]
  • Hope [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
  • Self-determination [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
  • Functional status [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]
  • Treatment relationship [ Time Frame: Baseline, 3 and 9 months ] [ Designated as safety issue: No ]

Enrollment: 71
Study Start Date: December 2006
Study Completion Date: May 2009
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Recovery Mentor: peer-based supportive care
Behavioral: Recovery Mentor
Provided Recovery Mentor services
No Intervention: 0
No Recovery Mentor, services as usual

Detailed Description:

The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The Recovery Guide model is just such a model. Beyond theoretical frameworks, the effectiveness of Recovery Guides has not been well studied. It is the intent of this study to conduct a randomized trial examining the effects of Recovery Guides on community tenure and integration. Furthermore, it is the intent of this study to to establish fidelity criteria.

Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
  • A history of two or more prior admissions within the past 18 months
  • Proficient in the use of the English language
  • A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features

Exclusion Criteria:

  • Inability to give signed, written consent
  • Primary DSM-IV diagnosis of substance abuse/dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00400166

Locations
United States, Connecticut
Yale-New Haven Psychiatric Hospital
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
Yale University
Connecticut State, Department of Mental Health and Addiction Services
Eli Lilly and Company
Investigators
Principal Investigator: William H Sledge, MD Yale University
  More Information

Additional Information:
No publications provided

Responsible Party: William H. Sledge, M.D.; Director, Yale Psychiatric Hospital; Chair, Yale Department of Psychiatry; George D & Esther S Gross Professor of Psychiatry, Yale University School of Medicine
ClinicalTrials.gov Identifier: NCT00400166     History of Changes
Other Study ID Numbers: 0607001641
Study First Received: November 15, 2006
Last Updated: June 10, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Yale University:
Peer support
Psychiatric disability
Mutual support
Psychiatric Rehabilitation

Additional relevant MeSH terms:
Depression
Schizophrenia
Disease
Bipolar Disorder
Psychotic Disorders
Depressive Disorder, Major
Behavioral Symptoms
Schizophrenia and Disorders with Psychotic Features
Mental Disorders
Pathologic Processes
Affective Disorders, Psychotic
Mood Disorders
Depressive Disorder

ClinicalTrials.gov processed this record on September 18, 2014